WallStreetZenWallStreetZen

NYSEMKT: CATX
Perspective Therapeutics Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for CATX

Based on 7 analysts offering 12 month price targets for Perspective Therapeutics Inc

Min Forecast
$8.00+168.46%
Avg Forecast
$12.71+326.64%
Max Forecast
$16.00+436.91%

Should I buy or sell CATX stock?

Based on 7 analysts offering ratings for Perspective Therapeutics Inc.

Strong Buy
Strong Buy
4 analysts 57.14%
Buy
3 analysts 42.86%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although CATX's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates CATX as a "Sell". Stocks with a Zen Rating of Sell have had an average return of -6.47% per year. Learn More

Be the first to know when Wall Street analysts revise their CATX stock forecasts and price targets.

CATX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-05-05
lockedlocked$00.00+00.00%2026-03-23
lockedlocked$00.00+00.00%2026-03-18Find Out Why
lockedlocked$00.00+00.00%2026-03-18
lockedlocked$00.00+00.00%2026-03-17
BTIG
Top 7%
94
Strong BuyReiterates$14.00+369.80%2026-03-17
Piper Sandler
Bottom 5%
5
Strong BuyInitiates Coverage On$16.00+436.91%2026-02-19

1 of 1

Forecast return on equity

Is CATX forecast to generate an efficient return?

Company
-33.48%
Industry
18.27%
Market
171.15%
CATX's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is CATX forecast to generate an efficient return on assets?

Company
-28.32%
Industry
14.23%
CATX is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

CATX earnings per share forecast

What is CATX's earnings per share in the next 3 years based on estimates from 17 analysts?

Avg 1 year Forecast
-$1.13
Avg 2 year Forecast
-$1.14
Avg 3 year Forecast
-$1.15

CATX revenue forecast

What is CATX's revenue in the next 3 years based on estimates from 15 analysts?

Avg 1 year Forecast
$388.0k-37.22%
Avg 2 year Forecast
$464.3k-24.87%
Avg 3 year Forecast
$416.1k-32.68%
CATX's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

CATX revenue growth forecast

How is CATX forecast to perform vs Medical Devices companies and vs the US market?

Company
-10.97%
Industry
8.5%
Market
14.14%
CATX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
CATX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

CATX vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
CATX$2.98$12.71+326.64%Strong Buy
ELMD$40.52$38.00-6.22%Strong Buy
CV$7.02$10.00+42.45%Buy
MOBI$11.99$20.25+68.89%Strong Buy
MASS$7.35N/AN/A
View Top Medical Device Stocks

Perspective Therapeutics Stock Forecast FAQ

Is Perspective Therapeutics Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 7 Wall Street analysts covering (NYSEMKT: CATX) stock is to Strong Buy CATX stock.

Out of 7 analysts, 4 (57.14%) are recommending CATX as a Strong Buy, 3 (42.86%) are recommending CATX as a Buy, 0 (0%) are recommending CATX as a Hold, 0 (0%) are recommending CATX as a Sell, and 0 (0%) are recommending CATX as a Strong Sell.

If you're new to stock investing, here's how to buy Perspective Therapeutics stock.

What is CATX's earnings growth forecast for 2026-2027?

(NYSEMKT: CATX) Perspective Therapeutics's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast earnings growth rate of 22.65%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 34.42%.

Perspective Therapeutics's earnings in 2026 is -$111,133,000.On average, 17 Wall Street analysts forecast CATX's earnings for 2026 to be -$129,202,937, with the lowest CATX earnings forecast at -$153,118,424, and the highest CATX earnings forecast at -$105,378,686. On average, 13 Wall Street analysts forecast CATX's earnings for 2027 to be -$129,830,191, with the lowest CATX earnings forecast at -$165,526,650, and the highest CATX earnings forecast at -$100,588,746.

In 2027, CATX is forecast to generate -$131,518,074 in earnings, with the lowest earnings forecast at -$169,438,435 and the highest earnings forecast at -$98,193,776.

What is CATX's revenue growth forecast for 2026-2027?

(NYSEMKT: CATX) Perspective Therapeutics's forecast annual revenue growth rate of -10.97% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.5%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 14.14%.

Perspective Therapeutics's revenue in 2026 is $618,000.On average, 15 Wall Street analysts forecast CATX's revenue for 2026 to be $44,246,161, with the lowest CATX revenue forecast at $8,494,161, and the highest CATX revenue forecast at $126,933,417. On average, 12 Wall Street analysts forecast CATX's revenue for 2027 to be $52,954,386, with the lowest CATX revenue forecast at $0, and the highest CATX revenue forecast at $152,137,627.

In 2027, CATX is forecast to generate $47,450,973 in revenue, with the lowest revenue forecast at $0 and the highest revenue forecast at $152,137,627.

What is CATX's forecast return on assets (ROA) for 2026-2029?

(NYSEMKT: CATX) forecast ROA is -28.32%, which is lower than the forecast US Medical Devices industry average of 14.23%.

What is CATX's Price Target?

According to 7 Wall Street analysts that have issued a 1 year CATX price target, the average CATX price target is $12.71, with the highest CATX stock price forecast at $16.00 and the lowest CATX stock price forecast at $8.00.

On average, Wall Street analysts predict that Perspective Therapeutics's share price could reach $12.71 by May 5, 2027. The average Perspective Therapeutics stock price prediction forecasts a potential upside of 326.64% from the current CATX share price of $2.98.

What is CATX's Earnings Per Share (EPS) forecast for 2026-2027?

(NYSEMKT: CATX) Perspective Therapeutics's current Earnings Per Share (EPS) is -$1.40. On average, analysts forecast that CATX's EPS will be -$1.13 for 2026, with the lowest EPS forecast at -$1.34, and the highest EPS forecast at -$0.92. On average, analysts forecast that CATX's EPS will be -$1.14 for 2027, with the lowest EPS forecast at -$1.45, and the highest EPS forecast at -$0.88. In 2027, CATX's EPS is forecast to hit -$1.15 (min: -$1.49, max: -$0.86).

What is CATX's forecast return on equity (ROE) for 2026-2029?

(NYSEMKT: CATX) forecast ROE is -33.48%, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.